Estimated reading time: 0 minutes, 36 seconds

EXACT 3Q EDGES UP

Exact, which markets the Macola, Progression and Synergy lines, saw revenue of almost $78 million, a rise by 2 percent when measured in euros for the third quarter ended September and license revenue started to show growth. The company said the latter was led by the Americas and the Netherlands.

EBIDTA, however, fell by 4 per cent to roughly $17 million, as the company increased its investment in Exact Online, which is not sold in the United States, and there was also an increase in the sale of third-party products. The company has not provided a 2010 financial outlook, but in a prepared statement, the company said its goal is to restore profitable organic revenue growth. Exact says it has also initiated programs to become more market driven.
Read 1703 times
Rate this item
(0 votes)

Visit other PMG Sites: